Medical
-
Memory formation influenced by how brain networks develop during youth
In a new, rare study of direct brain recordings in children and adolescents, a Northwestern Medicine scientist and colleagues from Wayne State...
-
Psilocybin treatment for major depression effective for up to a year for most patients, study shows
Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder...
-
A new atlas of cells that carry blood to the brain
While neurons and glial cells are by far the most numerous cells in the brain, many other types of cells play important roles. Among those are...
-
Opinion: Welcome back to the FDA, Robert Califf. Let’s get to work on your big idea
Now, more than ever, the U.S. needs scientific leaders who value Americans’ health and safety, who want to improve research and testing,...
-
Senate narrowly confirms Robert Califf to lead the FDA
WASHINGTON – The Senate voted Tuesday 50-46 to officially confirm Robert Califf as the commissioner of the Food and Drug Administration....
-
This family carried a rare mutation that should have been lethal. What was keeping them alive?
The result didn’t make sense. The researcher kept scanning the mouse’s pregnant belly, back and forth, back and forth. They could...
-
The new lightning rod in the fight over high drug prices
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in...
-
Signify Health snaps up a rival in the value-based care battle
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this...
-
STAT+: Pharmalittle: Califf moves closer to becoming FDA commish; U.S. states continue to push for drug-pricing bills
Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are enveloping the Pharmalot campus, where the official...
-
STAT+: Pharma companies rarely default on debt, but it remains a risk factor for investors
Pharmaceutical companies may not be known for defaulting on their debt, but a number of drug makers actually did so over the past few years,...
-
Opinion: Creating a digital Hippocratic oath for the 21st century
“First, do no harm.” Those four words, and the Hippocratic oath of which they are a part, have served as an ethical guide for...
-
Opinion: ‘I trust my drug dealer more than I trust this vaccine’
A patient who has taught me a lot about how to best care for people who use drugs floored me one afternoon while she was in the clinic when I...
-
STAT+: Private equity firms are cashing in on the travel nursing business that has boomed during the pandemic
WASHINGTON — As the U.S. health system buckles under the weight of the Covid-19 pandemic, private equity firms are cashing in. Some of...
-
With no votes to spare, Senate advances Califf’s FDA nomination toward final vote
WASHINGTON — In a dramatically close procedural vote Monday night, the Senate voted 49-45 to advance Robert Califf’s nomination to...
-
STAT+: Akili’s paperwork to go public lays bare the challenges ahead for digital therapeutics
Akili Interactive, the maker of a Food and Drug Administration-cleared video game to treat ADHD, has long been bullish on the tremendous...
-
Opinion: Controlled studies ease worries of widespread long Covid in kids
Uncertainty about the effect of Covid-19 on children is gradually being replaced by reassuring news. First, severe complications from Covid-19...
-
STAT+: No more waffling: Belgium discloses penalties for failing to report clinical trial results
In the latest move to crack down on wayward clinical trial sponsors, Belgium may now fine companies, hospitals, and universities that fail to...
-
STAT+: Pharmalittle: FTC may probe PBM contracts with pharmacies; Swiss voters reject animal testing ban
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so...
-
Opinion: Creating a promising pathway for faster access to new drugs — and a Califf confirmation
The FDA’s accelerated approval pathway has a potentially prominent champion — Robert Califf, the scientist President Biden has...
-
Opinion: Immunocompromised people need greater access to monoclonal antibodies
Fleets of delivery trucks leaving warehouses to distribute the first Covid-19 vaccine doses across the country in late December 2020 sent a...
-
STAT+: What we know — and still don’t know — about whether telehealth can cut costs
Telehealth proponents expected the pandemic to net them a windfall of convincing evidence that virtual care could increase quality and cut...
-
Why Covid-19 vaccines are a freaking miracle
Two years into the Covid-19 pandemic, it’s easy to lament all that has come to pass. The devastating losses. The upending of what we...
-
Opinion: ‘Brian’s Song’ at 50 still offers lessons about cancer for today
When “Brian’s Song” made its debut as an ABC Movie of the Week in 1971, this tear-jerker about a professional football...
-
How healthy is your state? New federal data ranks each
(HealthDay)—To live healthier and longer in the United States, it helps to have money and education—and if you live in Hawaii or California, your...
-
Large-scale cancer genetic analysis in the Middle East paves way for precision prevention program
A group of researchers at Qatar Foundation led by Dr. Lotfi Chouchane from Weill Cornell Medicine—Qatar (WCM-Q) have reported the first landscape...